Clinical Trial Update: Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating effectiveness and safety of Filgrastine in patients with breast cancer undergoing myelotoxic chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Filgrastine (Filgrastine)

Snippet

Sponsor: Blau Farmaceutica S.A. | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN